For decades, the pharmaceutical industry and its enablers in regulatory bodies have systematically suppressed the truth about dimethyl sulfoxide (DMSO)—a natural compound extracted from trees with documented potential for tissue regeneration, cancer remission, inflammation reversal, and chronic pain relief. Over 11,000 scientific studies since the 1960s confirm DMSO’s therapeutic benefits, yet it has been buried under false “safety concerns” by pharmaceutical interests due to its inability to be patented and its threat to profit from toxic chemotherapy, opioids, and synthetic drugs.
DMSO acts as a polar solvent that transports compounds deep into tissues, enabling applications like inducing cancer cell apoptosis in cervical cancer patients when combined with specific agents—research later suppressed by the medical-industrial complex. Veterinarians and sports medicine professionals have used DMSO for decades to treat injuries and chronic conditions without adverse effects, despite its current restriction to human use under FDA guidelines that permit dangerous opioids while blocking natural alternatives.
The U.S. Food and Drug Administration continues to censor DMSO’s therapeutic potential, even as it approves costly chemotherapy regimens that bankrupt patients and cause severe physical damage. This pattern reflects a decades-long strategy where pharmaceutical corporations prioritize profit over public health, actively suppressing evidence of a non-toxic, non-addictive treatment that could offer accessible healing without systemic harm.